论文部分内容阅读
PMAA 是我所研制的吖啶类抗癌化合物,动物实验证明本品可显著延长 L_(615),L_(1210),P_(388)白血病小鼠的生存期,对黑色素瘤 B_(16),Lewis 肺癌等实体瘤亦有明显的抑制作用。临床发现对多毛细胞
PMAA is an acridine anticancer compound developed by our institute. Animal experiments show that this product can significantly prolong the survival of L 615, L 1210, and P 388 leukemia mice, and inhibit the survival of melanoma B 16, Lewis lung cancer and other solid tumors also have significant inhibitory effect. Clinically found on hairy cells